Beijing Beilu Pharmaceutical Co., Ltd

SZSE:300016 Stock Report

Market Cap: CN¥3.0b

Beijing Beilu Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Xu Wang

Chief executive officer

CN¥1.8m

Total compensation

CEO salary percentagen/a
CEO tenure7.1yrs
CEO ownershipn/a
Management average tenure6.3yrs
Board average tenure5.4yrs

Recent management updates

Recent updates

Beijing Beilu Pharmaceutical Co., Ltd (SZSE:300016) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Oct 08
Beijing Beilu Pharmaceutical Co., Ltd (SZSE:300016) Stock Rockets 40% As Investors Are Less Pessimistic Than Expected

Subdued Growth No Barrier To Beijing Beilu Pharmaceutical Co., Ltd's (SZSE:300016) Price

Feb 27
Subdued Growth No Barrier To Beijing Beilu Pharmaceutical Co., Ltd's (SZSE:300016) Price

CEO

Xu Wang (40 yo)

7.1yrs

Tenure

CN¥1,762,200

Compensation

Mr. Xu Wang serves as General manager of Beijing Beilu Pharmaceutical Co., Ltd since December 11, 2017 and serves as its Chairman since August 01, 2019. He serves as Director at Beijing Beilu Pharmaceutica...


Leadership Team

NamePositionTenureCompensationOwnership
Xu Wang
Chairman & GM7.1yrsCN¥1.76mno data
Ni Zeng
Deputy GM5.4yrsCN¥687.20k0.083%
CN¥ 2.5m
Sen Li
Executive VP & COO2.4yrsCN¥1.65mno data
Li Zong
Deputy GM & Director9.8yrsCN¥901.70k0.033%
CN¥ 989.1k
Zehui Shao
Deputy GM6.3yrsCN¥804.50k0.077%
CN¥ 2.3m
Gen Chang Zheng
Chief Engineer & Employee Representative Member of Supervisory Boardno dataCN¥535.40kno data

6.3yrs

Average Tenure

43.5yo

Average Age

Experienced Management: 300016's management team is seasoned and experienced (6.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Xu Wang
Chairman & GM9.7yrsCN¥1.76mno data
Ni Zeng
Deputy GM5.4yrsCN¥687.20k0.083%
CN¥ 2.5m
Li Zong
Deputy GM & Director5.4yrsCN¥901.70k0.033%
CN¥ 989.1k
Zehui Shao
Deputy GM5.8yrsCN¥804.50k0.077%
CN¥ 2.3m
Gen Chang Zheng
Chief Engineer & Employee Representative Member of Supervisory Board16.6yrsCN¥535.40kno data
Qing Xiang
Non-Independent Director2.8yrsno datano data
Ying Yang
Chairman of Supervisory Board9.8yrsno datano data
Ying Dian Wang
Independent Director5.8yrsCN¥60.00kno data
Bin Zheng
Independent Director2.8yrsCN¥60.00kno data
Gang Cao
Independent Director2.8yrsCN¥60.00kno data
Wei Jiang
Supervisor2.8yrsno datano data
Fulong Wang
Director1.3yrsCN¥583.40k0.011%
CN¥ 318.7k

5.4yrs

Average Tenure

45.5yo

Average Age

Experienced Board: 300016's board of directors are considered experienced (5.4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/09 07:30
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Beijing Beilu Pharmaceutical Co., Ltd is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
Shuchang LiuChangjiang Securities Co. LTD.
Jie MaCinda Securities Co., Ltd